Press Release - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Company dossier
Alembic Pharmaceuticals
NSE:APLLTD · ISIN INE901L01018
- Close
- ₹811.95 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Alembic Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alembic Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter Ended 30Th June, 2026.BSE · financial results · pdf
Source filing Press Release - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing General Updates - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Record Date - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Updates - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Intimation Of Record Date For Payment Of Dividend On Equity Shares For The Financial Year Ended 31St March, 2026.BSE · corporate action · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Submission Of Notice Of The 16Th Annual General Meeting Of The Company.BSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Specimen Copy Of The Letter Sent To The Shareholders Under Regulation 36(1)(B) Of SEBI LODRBSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Credit Rating - Alembic Pharmaceuticals LimitedNSE · credit rating · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Archived filing Press Release - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Trading Window - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Press Release - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alembic Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alembic Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Press Release - Alembic Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alembic Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing